News

The overall risk of any infection in the first year after starting treatment is similar in people given different types of immune-modulating therapies for…

Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma that has returned or failed…

A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward, according to a new study.

September is Gynecologic Cancer Awareness Month, and advocacy groups are running campaigns to raise awareness about gynecological cancers, raise funds for research, and…

Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in an estimated 25.8 million life-years…

A novel mRNA vaccine effectively triggered an antitumor immune response in a mouse model of pancreatic cancer, even completely eliminating the cancer in a…

September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on blood cancer and fundraise to…

Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for blood draws to manage the…

A new CAR T-cell therapy designed to target multiple myeloma while sparing healthy immune cells has been given to its first patient in a…

The U.S. Food and Drug Administration (FDA) has approved an oral drug for adults with pancreatic adenocarcinoma, the most common form of pancreatic cancer,…